SENIN, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 7.348
EU - Europa 6.697
AS - Asia 3.903
SA - Sud America 654
Continente sconosciuto - Info sul continente non disponibili 339
AF - Africa 96
OC - Oceania 12
AN - Antartide 1
Totale 19.050
Nazione #
US - Stati Uniti d'America 7.053
IT - Italia 2.504
SG - Singapore 1.767
UA - Ucraina 952
SE - Svezia 716
IE - Irlanda 591
RU - Federazione Russa 559
BR - Brasile 508
VN - Vietnam 490
HK - Hong Kong 481
CN - Cina 461
FR - Francia 329
DE - Germania 312
FI - Finlandia 230
KR - Corea 188
GB - Regno Unito 172
CA - Canada 133
IN - India 86
CH - Svizzera 79
TR - Turchia 76
BD - Bangladesh 73
NL - Olanda 73
AR - Argentina 58
MX - Messico 41
BE - Belgio 35
PK - Pakistan 32
IQ - Iraq 31
PL - Polonia 28
ZA - Sudafrica 27
AT - Austria 25
ES - Italia 25
HN - Honduras 23
PH - Filippine 23
SA - Arabia Saudita 23
VE - Venezuela 23
ID - Indonesia 22
CR - Costa Rica 21
UZ - Uzbekistan 21
JP - Giappone 20
CO - Colombia 18
EC - Ecuador 17
GT - Guatemala 14
IR - Iran 14
JM - Giamaica 14
CL - Cile 13
LB - Libano 13
MY - Malesia 13
IL - Israele 12
RO - Romania 12
EG - Egitto 10
TT - Trinidad e Tobago 10
DZ - Algeria 9
JO - Giordania 9
KE - Kenya 9
MA - Marocco 9
NI - Nicaragua 8
NP - Nepal 8
CZ - Repubblica Ceca 7
GR - Grecia 7
LT - Lituania 7
PE - Perù 7
SC - Seychelles 7
SV - El Salvador 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BG - Bulgaria 6
ET - Etiopia 6
PR - Porto Rico 6
UY - Uruguay 6
EU - Europa 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
SY - Repubblica araba siriana 5
AL - Albania 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GP - Guadalupe 4
AO - Angola 3
BO - Bolivia 3
BY - Bielorussia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 18.694
Città #
Singapore 1.241
Chandler 782
San Jose 648
Dublin 591
Ashburn 577
Jacksonville 520
Hong Kong 480
San Mateo 315
Dong Ket 313
Boardman 248
Santa Clara 235
Council Bluffs 211
Seoul 187
Moscow 177
Wilmington 169
Milan 166
Ann Arbor 165
Princeton 164
Medford 158
Rome 147
Altamura 145
Lauterbourg 137
Lawrence 116
Beijing 110
Los Angeles 88
Andover 81
New York 81
Piscataway 78
The Dalles 77
Munich 70
Dallas 58
Naples 58
Ho Chi Minh City 52
Perugia 52
São Paulo 51
Hanoi 49
Redmond 49
Saint Petersburg 48
Izmir 47
Bologna 45
Helsinki 45
Woodbridge 44
Montreal 39
Padova 37
Bari 36
Des Moines 36
Norwalk 36
Turin 36
Turku 36
Frankfurt am Main 35
Genoa 34
Florence 33
Palermo 33
Toronto 33
Brussels 32
Phoenix 32
Chicago 30
Orem 30
London 29
Brooklyn 28
Falls Church 28
Brescia 27
Prato 26
Boston 24
Denver 24
Houston 22
San Paolo di Civitate 22
Shanghai 22
Atlanta 21
Chennai 19
Auburn Hills 18
Tokyo 18
Carrboro 17
North Bergen 17
San Francisco 17
Verona 17
Warsaw 17
Amsterdam 16
Redwood City 16
Columbus 15
Haiphong 15
San José 15
Baghdad 14
Belo Horizonte 14
Brasília 14
Stockholm 14
Ardabil 13
Civitavecchia 13
Johannesburg 13
Mexico City 13
Nuremberg 13
Rio de Janeiro 13
Caserta 12
Napoli 12
Venice 12
Bergamo 11
Parma 11
Guatemala City 10
Monmouth Junction 10
Philadelphia 10
Totale 10.335
Nome #
Validazione della versione italiana della Geriatric Depression Scale a 5 item in tre differenti setting assistenziali 1.844
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani. 467
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 296
Paziente anziano, paziente geriatrico e medicina della complessità. Fondamenti di Gerontologia e Geriatria (III edizione) 199
Linee Guida sull'utilizzazione della Valutazione multidimensionale per l'anziano fragile nella rete dei servizi 188
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 174
Antiossidanti plasmatici e longevità: studio su centenari sani 169
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 169
The brain of the elderly between normality and pathology: Techniques and technologies for the evaluation 168
Axonal injury within language network in primary progressive aphasia 167
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. 164
Dementia, depression and parkinsonism: A frequent association in the elderly. 160
Platelet MAO-B activity and vitamin B12 in old age dementias. 158
H-1-MR spectroscopy differentiates mild cognitive impairment from normal brain aging 157
Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study 151
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study 151
Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia 149
La risonanza magnetica spettroscopica differenzia il Mild Cognitive Impairment dal normale invecchiamento cerebrale 149
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics. 147
Discovering the origins of the frail elderly Alla scoperta delle origini dell’anziano fragile 147
Influenza della comorbilità e dello stato cognitivo sulle attività strumentali della vita quotidiana nei soggetti con Mild Cognitive Impairment Amnesico (aMCI): risultati del Progetto ReGAl. 147
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 146
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. 146
Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity. 146
White blood cell count and mortality in the Baltimore Longitudinal Study of Aging 144
Altered mitochondrial membrane fluidity in AD brain. 143
Uric acid and inflammatory markers 143
Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle 139
Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity 138
Blood pressure and functional aspects of the aging brain. 138
Antioxidant profile and early outcome in stroke patients. 138
Deterioramento cognitivo e sviluppo di sindromi geriatriche durante il ricovero ospedaliero: risultati dello studio GIFA 137
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 137
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease. 137
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. 137
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 136
Alterazioni biochimiche nel cervello di soggetti con ipertensione cronica e in pazienti con demenza di Alzheimer in fase precoce valutate mediante risonanza magnetica spettroscopica 135
The effects of aging and endurance exercise on cardiovascular performance in healthy elderly: a review of the literature. 135
Oxidative stress and dementia: new perspectives in AD pathogenesis. 133
Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study 133
Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. 133
Age and sex influence on oxidative damage and functional status in human skeletal muscle. 133
Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: the ELderly and LErcanidipine (ELLE) study. 132
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 132
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 132
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 131
Validation of the five-item geriatric depression scale in elderly subjects in three different settings. 130
Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic MCI: Results from the ReGAl project. 128
Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. 126
Superficial siderosis of the central nervous system: a 70-year-old man with ataxia, depression and visual deficits 126
Acido urico e marker di infiammazione nella popolazione anziana dello studio InChIAnTI 125
Antiossidanti plasmatici e prognosi a breve termine nel paziente anziano con ictus ischemico acuto 123
Is multi-infarct dementia representative of vascular dementias? A retrospective study 122
Il ruolo dei fattori di rischio vascolare nei sottotipi di mild cognitive impairment. Risultati del progetto ReGAl 122
Calcium metabolism and vitamin D in the extreme longevity 121
Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study. 121
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 120
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. 120
[Drinking-water and cardiovascular mortality]. 120
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 120
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. 118
Area-specific differences in OH8dG and mtDNA4977 levels in Alzheimer disease patients and aged controls. 117
Paziente anziano, Paziente geriatrico 115
Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study 115
Neuropsychological assessment of the severely impaired elderly patient: validation of the Italian short version of the Severe Impairment Battery (SIB). 115
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. 115
Appendicular cortical bone loss after age 65: a sex dependent event? 114
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 113
Plasma levels of lipophilic antioxidants in very old subjects with type 2 diabetes 113
Health Care for Older People in Italy: The U.L.I.S.S.E. Project (Un Link Informatico sui Servizi Sanitari Esistenti per l'anziano - A Computerized Network on Health Care Services for Older People). 112
Depression in the elderly: new concepts and therapeutic approaches. 112
Physical activity and oxidative stress during aging 112
Impact of the earthquake of September 26, 1997 in Umbria, Italy on the socioenvironmental and psychophysical conditions of an elderly population 111
Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type. 111
Physical activity and cardiovascular health in the elderly 111
Oxidative damage to lymphocyte DNA from AD patients. 111
Use of artificial networks in clinical trials: a pilot study to predict responsiveness to donepezil in Alzheimer's disease. 110
The problem of arteriovenous malformation of the spinal cord in the elderly: case report of an octogenarian 108
Uric acid and dementia in community-dwelling older persons 108
Frattura di femore nelle residenze per anziani della provincia di Perugia: uno studio italiano su prevalenza, latenza, fattori di rischio ed impatto sulla mobilità 107
Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study 105
Vascular Risk Factors in Mild Cognitive Impairment Subtypes. Findings from the ReGAl Project. 105
Topics in clinical pharmacology: cardiovascular and diabetes mellitus. 102
Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia 102
Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy? 101
Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity 100
Pathogenetic mechanisms in vascular dementia. 100
Catepsin D polymorphism in italian elderly subjects with sporadic late onset Alzheimer’s disease 100
Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. 100
Hypertension and Cognitive Function in the Elderly. 99
Prescription of anti-oedema agents and short-term mortality in older patients with acute ischaemic stroke 99
Elderly stroke patient at risk for dementia: in search of a profile 98
Autoantibodies against oxidized low-density lipoproteins in older stroke patients. (Letter) 98
Cognitive enhancement therapy for Alzheimer's disease. The way forward. 98
Il trattamento della depressione nell’anziano. Documento di consenso dell’Associazione Italiana di Psicogeriatria. 97
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 97
Le demenze vascolari 96
Treatment with ACE inhibitors is associated with a reduction in short term mortality in older patients with severe acute ischemic stroke 96
Markers of inflammation, Vitamin E and peripheral nervous system function The InCHIANTI study 95
Elderly patients with cognitive impairment have a high risk for functinal decline during hospitalization: The GIFA Study 94
Totale 14.909
Categoria #
all - tutte 74.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022957 0 0 0 0 66 41 47 407 28 24 153 191
2022/20232.482 180 450 31 248 223 246 9 124 838 7 87 39
2023/20241.088 77 131 56 46 32 14 150 71 176 29 176 130
2024/20252.394 72 238 90 89 270 126 73 212 512 160 371 181
2025/20264.968 375 401 232 667 601 480 743 277 629 349 127 87
2026/20271.942 129 298 408 975 132 0 0 0 0 0 0 0
Totale 19.050